Daniell Richard

Exec. VP, European Commercial

1 company

Weak

Trades Analyzed

12M Win Rate

7.1%

Avg 3M Return

-5.7%

Avg 12M Return

-40.2%

Daniell Richard is an Exec. VP, European Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD. Recent SEC Form 4 filings include 0 buys and 13 sells.

Estimated insider holdings value: $5.3M based on current market prices.

Holdings by Company

TEVADec 9, 2025

Current Shares148.8K

Value$5.32M

Net Activity-979,517

Bought: 0Sold: 979.5K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 7, 2022	TEVA Teva Pharmaceutical Industries Ltd	Exec. VP, European Commercial	Sale+OE	58,952	$7.44	$438,494.04	-35.6%	+23.6%	+28.8%
Feb 28, 2022	TEVA Teva Pharmaceutical Industries Ltd	Exec. VP, European Commercial	Sale+OE	20,598	$8.14	$167,713.04	-50.4%	+11.9%	+21.9%
Feb 9, 2022	TEVA Teva Pharmaceutical Industries Ltd	Exec. VP, European Commercial	Sale+OE	13,135	$9.06	$119,009.67	-39.3%	-16.7%	+9.2%
Mar 4, 2021	TEVA Teva Pharmaceutical Industries Ltd	Exec. VP, European Commercial	Sale+OE	7,513	$10.58	$79,520.60	-27.0%	-	-
Mar 3, 2021	TEVA Teva Pharmaceutical Industries Ltd	Exec. VP, European Commercial	Sale+OE	993	$10.88	$10,803.44	-7.7%	-	-
Mar 1, 2021	TEVA Teva Pharmaceutical Industries Ltd	Exec. VP, European Commercial	Sale+OE	20,598	$10.85	$223,506.84	-65.7%	-	-
Feb 9, 2021	TEVA Teva Pharmaceutical Industries Ltd	Exec. VP, European Commercial	Sale+OE	68,422	$12.72	$870,389.42	-47.1%	-	-
Sep 9, 2020	TEVA Teva Pharmaceutical Industries Ltd	Exec. VP, European Commercial	Sale+OE	333	$8.98	$2,991.81	-3.0%	-	-
Mar 17, 2020	TEVA Teva Pharmaceutical Industries Ltd	Exec. VP, European Commercial	Sale+OE	616	$7.17	$4,417.58	-5.6%	-	-
Mar 3, 2020	TEVA Teva Pharmaceutical Industries Ltd	Exec. VP, European Commercial	Sale+OE	991	$11.77	$11,659.81	-9.3%	-	-